MoneyWorks4Me

Nutraplus India - Quaterly Results

11 Feb 2026 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended December 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended December 2025 is Rs. -0.20 millions as compared to Net Loss of Rs. -0.20 millions of corresponding quarter ended December 2024 Operating profit Margin for the quarter ended December 2025 improved to -0.20% as compared to -0.20% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00
Other Income 0.00 0.00 0.00 0.97 0.00 0.00 0.00 6.20 0.00
PBIDT -0.20 -0.20 0.00 -4.03 -2.49 61.85 -1.28 -30.32 -95.78
Interest 0.00 0.00 0.00 0.00 0.55 -100.00 0.29 0.00 0.00
PBDT -0.20 -0.20 0.00 -4.03 -3.04 32.57 -1.57 -30.32 -94.82
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.20 -0.20 0.00 -4.03 -3.04 32.57 -1.57 -30.32 -94.82
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.20 -0.20 0.00 -4.03 -3.04 32.57 -1.57 -30.32 -94.82
Equity 170.46 170.46 0.00 170.46 170.46 0.00 170.46 170.46 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3093.88 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..